Who has been buying Neuromeca stock?

12 distinct insiders have filed 16 disclosed insider purchases in Neuromeca (348340), most recently on 2026-07-08. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Neuromeca have?

Neuromeca has 16 buy-side and 15 sell-side disclosures on record, covering ₩3.8B ($2.6M) in total reported value, spanning 2024-04-07 to 2026-07-08.

Where does StockDrifts get Neuromeca insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Neuromeca 348340

Company

뉴로메카Neuromeca

Insiders

Buys

Total Value

₩3.8B ($2.6M)

Avg Return

+24.62%

Last Filing

2026-07-08

Neuromeca (348340) has 16 disclosed insider purchases and 15 disclosed disposals on record, filed by 12 distinct insiders. Together those filings cover ₩3.8B ($2.6M) in reported transaction value. The earliest filing StockDrifts holds for Neuromeca is dated 2024-04-07; the most recent is 2026-07-08. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +24.62%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-08-06	BUY	PROGRAM	허영진 Youngjin Heo	master	37.9K	₩19,870	+4.2%	₩752M ($522K)
2026-08-06	BUY	PROGRAM	박종훈 Park Jong-hoon	CEO	1.1M	₩19,870	+4.2%	₩22.6B ($15.7M)
2026-08-06	BUY	PROGRAM	정종필 Jongpil Jeong	director	10.7K	₩19,870	+4.2%	₩212M ($147K)
2026-08-06	BUY	PROGRAM	박종석 Park Jong-seok	director	33.0K	₩19,870	+4.2%	₩656M ($455K)
2026-08-06	BUY	PROGRAM	강준수 Junsu Kang	director	6.3K	₩19,870	+4.2%	₩125M ($87K)
2026-08-06	BUY	PROGRAM	심규분 Shim Gyu-Bun	director	235	₩19,870	+4.2%	₩5M ($3K)
2026-08-06	BUY	PROGRAM	최은재 Eunjae Choi	director	2.0K	₩19,870	+4.2%	₩40M ($28K)
2026-08-06	BUY	PROGRAM	박형일 Park Hyeong-il	director	2.0K	₩19,870	+4.2%	₩40M ($28K)
2026-08-05	SELL	기타	강준수 Junsu Kang	director	-2.6K	₩21,500	+3.7%	₩55M ($38K)
2026-08-05	SELL	기타	박종훈 Park Jong-hoon	CEO	-85.3K	₩21,500	+3.7%	₩1.8B ($1.3M)
2026-08-05	BUY	PROGRAM	박종석 Park Jong-seok	director	917	₩21,500	-3.7%	₩22M ($16K)
2026-08-05	BUY	PROGRAM	박종훈 Park Jong-hoon	CEO	40.0K	₩21,500	-3.7%	₩978M ($679K)
2026-08-05	BUY	PROGRAM	박종훈 Park Jong-hoon	CEO	102.4K	₩21,500	-3.7%	₩2.5B ($1.7M)
2026-08-05	BUY	PROGRAM	박형일 Park Hyeong-il	director	4.0K	₩21,500	-3.7%	₩98M ($68K)
2026-08-05	BUY	PROGRAM	최은재 Eunjae Choi	director	4.0K	₩21,500	-3.7%	₩98M ($68K)
2026-08-05	BUY	PROGRAM	심규분 Shim Gyu-Bun	director	110	₩21,500	-3.7%	₩3M ($2K)
2026-08-05	BUY	PROGRAM	강준수 Junsu Kang	director	2.6K	₩21,500	-3.7%	₩63M ($44K)
2026-08-05	SELL	기타	박종석 Park Jong-seok	director	-917	₩21,500	+3.7%	₩20M ($14K)
2026-08-05	SELL	기타	심규분 Shim Gyu-Bun	director	-92	₩21,500	+3.7%	₩2M ($1K)
2026-07-20	SELL	Market Sell	박종석 Park Jong-seok	director	-15.8K	-	-	-
2026-07-20	SELL	Market Sell	허영진 Youngjin Heo	master	-5.7K	₩28,150	+4.8%	₩159M ($111K)
2026-07-16	SELL	Market Sell	허영진 Youngjin Heo	master	-8.6K	₩30,400	+11.8%	₩260M ($181K)
2026-07-14	SELL	Market Sell	허영진 Youngjin Heo	master	-5.3K	₩29,500	+9.2%	₩156M ($108K)
2026-07-13	SELL	Market Sell	정종필 Jongpil Jeong	director	-5.5K	₩30,650	+12.6%	₩168M ($117K)
2026-07-08	SELL	시간외매매	박종훈 Park Jong-hoon	CEO	-80.0K	₩30,450	-5.3%	₩2.4B ($1.7M)
2026-07-08	SELL	장외매도	박종훈 Park Jong-hoon	CEO	-483.6K	₩30,450	-5.3%	₩14.7B ($10.2M)
2026-07-02	BUY	기타	허영진 Youngjin Heo	master	19.5K	₩34,600	-7.4%	₩675M ($469K)
2026-07-02	BUY	기타	박종석 Park Jong-seok	director	16.8K	₩34,600	-7.4%	₩580M ($403K)
2026-07-02	BUY	기타	정종필 Jongpil Jeong	director	5.5K	₩34,600	-7.4%	₩190M ($132K)
2026-07-02	BUY	기타	박종훈 Park Jong-hoon	CEO	569.0K	₩34,600	+3.2%	₩19.7B ($13.7M)
2026-07-02	BUY	기타	강준수 Junsu Kang	director	2.6K	₩34,600	-7.4%	₩89M ($62K)
2026-07-02	BUY	기타	심규분 Shim Gyu-Bun	director	92	₩34,600	-7.4%	₩3M ($2K)
2026-05-19	BUY	주식매수선택권	허영진 Youngjin Heo	master	6.5K	₩59,800	-7.2%	₩389M ($270K)
2026-05-19	BUY	주식매수선택권	이재천 Jaecheon Lee	master	12.0K	₩59,800	-7.2%	₩718M ($498K)
2026-05-19	BUY	주식매수선택권	정종필 Jongpil Jeong	director	7.0K	₩59,800	-7.2%	₩419M ($291K)
2026-01-30	BUY	주식매수선택권	허영진 Youngjin Heo	master	1.5K	₩91,800	-17.1%	₩138M ($96K)
2026-01-30	BUY	주식매수선택권	강준수 Junsu Kang	director	8.5K	₩91,800	-17.1%	₩780M ($542K)
2026-01-28	SELL	Market Sell	강준수 Junsu Kang	director	-10.0K	₩95,700	+20.5%	₩957M ($665K)
2026-01-28	SELL	Market Sell	심규분 Shim Gyu-Bun	director	-300	₩95,700	+20.5%	₩29M ($20K)
2026-01-02	SELL	Market Sell	강준수 Junsu Kang	director	-9.9K	₩34,100	-123.2%	₩339M ($235K)
2025-12-10	BUY	주식매수선택권	허영진 Youngjin Heo	master	5.0K	₩33,700	+125.8%	₩169M ($117K)
2025-11-21	SELL	Market Sell	신윤호 Shin Yunho	director	-3.0K	₩28,250	-169.4%	₩84M ($58K)
2025-11-07	SELL	Market Sell	이재천 Jaecheon Lee	master	-13.9K	₩28,800	-164.2%	₩401M ($278K)
2025-11-04	SELL	Market Sell	최윤서 Choi Yunseo	master	-20.0K	₩33,650	-126.2%	₩673M ($467K)
2025-07-03	BUY	주식매수선택권	강준수 Junsu Kang	director	11.5K	₩23,700	+221.1%	₩273M ($189K)
2025-06-25	BUY	Market Buy	강준수 Junsu Kang	director	200	₩25,450	+199.0%	₩5M ($4K)
2025-06-25	SELL	Market Sell	강준수 Junsu Kang	director	-500	₩25,450	-199.0%	₩13M ($9K)
2025-06-25	SELL	Market Sell	강준수 Junsu Kang	director	-1.1K	₩25,450	-199.0%	₩29M ($20K)
2025-06-16	SELL	Market Sell	서영호 Youngho Seo	master	-1.0K	₩22,600	-236.7%	₩23M ($16K)
2025-05-26	SELL	Market Sell	서영호 Youngho Seo	master	-500	₩23,650	-221.8%	₩12M ($8K)

Showing the 50 most recent of 76 filings.

Frequently asked questions

Who has been buying Neuromeca stock?: 12 distinct insiders have filed 16 disclosed insider purchases in Neuromeca (348340), most recently on 2026-07-08. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Neuromeca have?: Neuromeca has 16 buy-side and 15 sell-side disclosures on record, covering ₩3.8B ($2.6M) in total reported value, spanning 2024-04-07 to 2026-07-08.
Where does StockDrifts get Neuromeca insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Neuromeca. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.